(IN BRIEF) BioNTech and OncoC4 have entered into an exclusive license and collaboration agreement to develop and commercialize OncoC4’s anti-CTLA-4 monoclonal antibody candidate, ONC-392. The candidate aims to delete immunosuppressive T cells in the tumor microenvironment but spare T cells … Read the full press release
Posted in Germany, Management, News, Pharma & Biotech, Science, Technology
Tagged anti-CTLA-4 monoclonal antibody, BioNTech, Germany, ONC-392, OncoC4, Prof. Ugur Sahin, T cells, Yang Liu
BIRMINGHAM, 19-Apr-2017 — /EuropaWire/ — A new study has identified novel mechanisms whereby T cells may be able to distinguish an emerging class of targets specifically increased on cancer cells. The study, carried out by researchers from the University of Birmingham … Read the full press release
16-8-2013 — /EuropaWire/ — Immunologists at LMU have come up with a new technique that can be used both to fight tumors and to treat autoimmune diseases. A new grant from the Federal Ministry for Education and Research will enable the … Read the full press release
Posted in Education, Germany, Healthcare, Pharma & Biotech, Science
Tagged autoimmune disease, autoimmune diseases, BMBF, Clinical Neuroimmunology, Cytotoxic T cells, fight tumors, LMU, multiple sclerosis, pathogen-derived protein fragments, peptides, Privatdozent Dr. Klaus Dornmair, Prof. Jörg Prinz, psoriasis, T cells, treat autoimmune diseases, tumor-specific antigens, tumors, Validation of the Innovation Potential of Scientific Research
06-8-2013 — /EuropaWire/ — Researchers at Karolinska Institutet in Sweden have identified a new stabilizing agent of atherosclerotic plaques. These findings have been published in Science Translational Medicine, and show how the immune system can improve the condition in blood vessels … Read the full press release
Posted in Education, Healthcare, Science, Sweden
Tagged accumulation of cholesterol, Anna M Lundberg, Anna-Karin Robertson, Anton Gisterå, Atherosclerosis, avoid heart attacks, blood vessels, Daniel FJ Ketelhuth, Göran K. Hansson, immune cells, immune system, inflammatory disease, John Andersson, Karolinska Institutet, Karolinska Institutet researchers, Ming O Li, Olga Ovchinnikova, Richard A Flavell, Science Translational Medicine, stabilizing agent of atherosclerotic plaques, Stefan K Nilsson, stroke, T cells, vessel walls
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
